Contributors to US Excessive Drug Pricing
Research - Drug pricing in the US is not a straightforward process. For the most part, this is done by design. Politicians and media have put the … Continue Reading
Read nowMust Read
Obesity & PD-1: History Doesn’t Repeat But It Rhymes
The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical Submits 510(k) for Insulin Patch Pump
Modular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLatest Posts
Combos Could be Next Paradigm in Obesity Treatments
Insights - With Thanksgiving weekend here, food is atop the mind of all Americans. We thought it only appropriate to give an update on the obesity field. … Continue Reading
Read now
Radiopharmaceutical Space Rolling as Eli Lilly Acquires Point
Research - This morning, Eli Lilly (LLY) acquired Point Bio (PNT) for $12.50/share, an 87% premium. The $1.4B price tag gives Lilly a strong presence in radiopharmaceuticals … Continue Reading
Read now
Structure (GPCR) Rallies on Oral GLP-1 & Abbott Claims CGM Tech A Companion to GLP
Insights - Structure Therapeutics (GPCR) is up more than 35% this morning after announcing Phase 1b data of its oral GLP-1 receptor agonist, GSBR-1290, in overweight patients. … Continue Reading
Read now
Transcript Immunovant (IMVT) IMVT-1402 Phase 1 SAD & MAD Results
Transcripts - Operator Good morning. My name is Michelle, and I’m your conference call operator. As a reminder, this call is being recorded. Before we begin, I … Continue Reading
Read now
Transcript: Soleno (SLNO) Data of DCCR for Prader-Willi Syndrome
Transcripts - Operator Greetings. Welcome to Soleno Therapeutics Randomized Withdrawal Period of Study C602 Top Line Results. [Operator Instructions] Please note, this conference is being recorded.At this … Continue Reading
Read now
Transcript: Cardiff (CRDF) Phase 2 Onvansertib Data in Pancreatic & SCLC
Transcripts - Operator Welcome to the Cardiff Oncology Clinical Development Update Conference Call. [Operator Instructions] As a reminder, this call is being recorded today, Tuesday, September 26, … Continue Reading
Read now